Compare Stocks Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDigital Media StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare ShareLink copied to clipboard. NASDAQ:DOCS Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDOCSDoximity$41.74-0.6%$40.55$19.89▼$44.88$7.75B1.291.67 million shs1.03 million shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for November 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDOCSDoximity+0.25%+1.38%-3.63%+53.27%+105.48%Urgent: This election is rigged (Ad)If you missed it, my emergency election broadcast is now available - but will be removed soonClick here to watch it now.MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationDOCSDoximity3.3902 of 5 stars2.20.00.00.03.34.22.5Analyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDOCSDoximity2.33Hold$36.42-12.75% DownsideCurrent Analyst RatingsLatest DOCS, NFC, CURY, and WOSG Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails10/30/2024DOCSDoximityMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetUnderweight ➝ Underweight$26.00 ➝ $33.0010/15/2024DOCSDoximityBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeEqual Weight ➝ Overweight$35.00 ➝ $52.0010/8/2024DOCSDoximityEvercore ISISubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetIn-Line ➝ In-Line$34.00 ➝ $45.0010/7/2024DOCSDoximityBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$32.00 ➝ $45.009/17/2024DOCSDoximityBaird R WSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy9/17/2024DOCSDoximityRobert W. BairdSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$41.00 ➝ $45.008/20/2024DOCSDoximityCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$37.00 ➝ $40.008/19/2024DOCSDoximityJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$27.00 ➝ $30.008/14/2024DOCSDoximityTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingHold ➝ Hold$31.00 ➝ $35.008/9/2024DOCSDoximityEvercore ISISubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetIn-Line ➝ In-Line$29.00 ➝ $34.00(Data available from 10/31/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDOCSDoximity$493.63M15.70$0.87 per share47.71$4.83 per share8.64Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDOCSDoximity$147.58M$0.8052.1848.535.2932.53%19.26%16.37%11/7/2024 (Confirmed)Latest DOCS, NFC, CURY, and WOSG EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails11/7/2024N/ADOCSDoximity$0.2560N/A-$0.2560N/AN/AN/A 8/8/2024Q1 2025DOCSDoximity$0.16$0.22+$0.06$0.23$119.88 million$126.68 millionDividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthDOCSDoximityN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioDOCSDoximityN/A6.726.72OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDOCSDoximity87.19%Insider OwnershipCompanyInsider OwnershipDOCSDoximity37.40%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableDOCSDoximity890185.66 million116.22 millionNot OptionableDOCS, NFC, CURY, and WOSG HeadlinesRecent News About These CompaniesDoximity to Present at the Jefferies London Healthcare ConferenceOctober 31 at 4:46 PM | finance.yahoo.comWhat Factors Have Led to Doximity Inc (DOCS) Stock Trading -6.68% Below Its 52-Week High?October 31 at 11:44 AM | bovnews.comDoximity (DOCS) to Release Quarterly Earnings on ThursdayOctober 31 at 4:11 AM | americanbankingnews.comDoximity (DOCS) Scheduled to Post Earnings on ThursdayOctober 31 at 4:08 AM | marketbeat.comMorgan Stanley Forecasts Strong Price Appreciation for Doximity (NASDAQ:DOCS) StockOctober 30 at 2:29 PM | marketbeat.comHigh Valuation and Modest Growth Projections Lead to Sell Rating on DoximityOctober 30 at 1:34 PM | markets.businessinsider.comTwin Peaks Wealth Advisors LLC Invests $872,000 in Doximity, Inc. (NASDAQ:DOCS)October 30 at 10:43 AM | marketbeat.comDoximity (DOCS) Outperforms Broader Market: What You Need to KnowOctober 29 at 7:20 PM | zacks.comCautious Outlook: Sell Rating on Doximity Due to Premium Valuation and Declining Engagement MetricsOctober 29 at 4:30 AM | markets.businessinsider.comDoximity (DOCS) Sees a More Significant Dip Than Broader Market: Some Facts to KnowOctober 23, 2024 | zacks.comDoximity Inc (DOCS) Stock Posted a Gross Margin of 89.65% Over the Past Year: Is This Justifiable?October 22, 2024 | bovnews.comBarclays Issues Overweight Rating for Doximity Inc (DOCS) StockOctober 19, 2024 | bovnews.comWhat’s Behind the 1.49% Gain in Doximity Inc (DOCS) Stock? Find Out Now!October 19, 2024 | bovnews.comFriedenthal Financial Acquires New Holdings in Doximity, Inc. (NASDAQ:DOCS)October 19, 2024 | marketbeat.comDoximity, Inc. (NASDAQ:DOCS) Shares Sold by Swedbank ABOctober 18, 2024 | marketbeat.com3 Medical Services Stocks to Buy to Navigate Industry ChallengesOctober 17, 2024 | zacks.comBarclays Upgrades Doximity (DOCS)October 17, 2024 | msn.comDoximity (NASDAQ:DOCS) Shares Gap Up - Here's What HappenedOctober 15, 2024 | marketbeat.comDoximity Inc (DOCS) Stock Price Reaches $41.96: What Factors Are Influencing This Level?October 15, 2024 | bovnews.comDoximity (NASDAQ:DOCS) Upgraded to "Overweight" at BarclaysOctober 15, 2024 | marketbeat.comAQR Capital Management LLC Sells 29,523 Shares of Doximity, Inc. (NASDAQ:DOCS)October 13, 2024 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCompany DescriptionsDoximityNASDAQ:DOCSDoximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical manufacturers and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
